Trial Profile
To Assess Left Ventricular Contractile Reserve in Patients With Coronary Microvascular Disfunction, and the effect of Ivabradine on this parameter
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2018
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 16 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association